4 years ago
FATE
AnalystsRobert BurnsRobert Burns's Stock Forecasts
AnalystsRobert Burns
Sectors:
Industries:
Analyst Ranking
Top 5%
#267 out of 5515 analysts
Average Return
+6.23%
Win Rate
42%271 out of 649
Risk vs Reward
Poor
Good
Robert Burns's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Tango Therapeutics IncTNGX | +1,388.81% | $1.34 | $19.95 | 2025-04-14 - 2026-04-10 | Buy |
Prelude Therapeutics IncPRLD | +620.13% | $0.61 | $4.40 | 2025-04-08 - 2026-04-07 | Buy |
Cogent Biosciences IncCOGT | +488.51% | $5.31 | $31.25 | 2025-05-20 - 2026-05-19 | Buy |
Relay Therapeutics IncRLAY | +481.07% | $3.54 | $20.57 | 2025-08-26 - 2026-08-25 | Buy |
IMMIX Biopharma IncIMMX | +478.10% | $2.10 | $12.14 | 2025-09-12 - 2026-09-11 | Buy |
Robert Burns Analyst Color
Get additional color on Robert Burns's coverage of popular stocks
Robert Burns's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Adicet Bio IncACET | 5 | Buy | $27.00 | +194.12% | Reiterates | 3 days ago |
Telix Pharmaceuticals LtdTLX | 9 | Buy | $20.00 | +58.86% | Reiterates | 6 days ago |
Cogent Biosciences IncCOGT | 18 | Buy | $55.00 | +74.60% | Reiterates | 6 days ago |
Cardiff Oncology IncCRDF | 6 | Buy | $9.00 | +556.93% | Upgrades | 6 days ago |
Pmv Pharmaceuticals IncPMVP | 12 | Buy | $5.00 | +233.33% | Reiterates | 17 days ago |
Blossomhill Therapeutics IncBLSM | 1 | Buy | $35.00 | +35.98% | Initiates Coverage On | 20 days ago |
Revolution Medicines IncRVMD | 24 | Buy | $280.00 | +46.64% | Maintains | 25 days ago |
Zymeworks IncZYME | 27 | Buy | $55.00 | +107.00% | Maintains | a month ago |
Inhibrx Biosciences IncINBX | 1 | Buy | $245.00 | +124.05% | Initiates Coverage On | a month ago |
Relay Therapeutics IncRLAY | 25 | Buy | $29.00 | +53.93% | Maintains | a month ago |
Elicio Therapeutics IncELTX | 12 | Buy | $23.00 | +1,116.93% | Reiterates | a month ago |
Tango Therapeutics IncTNGX | 15 | Buy | $68.00 | +212.64% | Maintains | a month ago |
Arrivent Biopharma IncAVBP | 13 | Buy | $47.00 | +62.63% | Maintains | a month ago |
Cullinan Therapeutics IncCGEM | 7 | Buy | $30.00 | +42.31% | Reiterates | a month ago |
IMMIX Biopharma IncIMMX | 14 | Buy | $25.00 | +100.00% | Maintains | a month ago |
Oric Pharmaceuticals IncORIC | 31 | Buy | $27.00 | +111.10% | Maintains | a month ago |
Karyopharm Therapeutics IncKPTI | 7 | Hold | $3.00 | +59.57% | Downgrades | 2 months ago |
Prelude Therapeutics IncPRLD | 19 | Buy | $8.00 | +64.27% | Reiterates | 2 months ago |
Nuvation Bio IncNUVB | 20 | Buy | $21.00 | +258.97% | Maintains | 2 months ago |
Onkure Therapeutics IncOKUR | 6 | Buy | $21.00 | +611.86% | Maintains | 2 months ago |
Nurix Therapeutics IncNRIX | 26 | Buy | $34.00 | +33.65% | Maintains | 2 months ago |
Enliven Therapeutics IncELVN | 7 | Buy | $64.00 | +29.42% | Maintains | 2 months ago |
Exelixis IncEXEL | 17 | Buy | $56.00 | -4.04% | Reiterates | 3 months ago |
Adc Therapeutics SaADCT | 23 | Hold | N/A | N/A | Downgrades | 3 months ago |
Fate Therapeutics IncFATE | 9 | Buy | $7.00 | +176.68% | Reiterates | 3 months ago |
Radiopharm Theranostics LtdRADX | 1 | Buy | $16.00 | +869.70% | Initiates Coverage On | 4 months ago |
Aktis Oncology IncAKTS | 3 | Buy | $35.00 | +59.96% | Maintains | 4 months ago |
Bolt Biotherapeutics IncBOLT | 3 | Buy | $7.00 | +96.63% | Reiterates | 4 months ago |
Caribou Biosciences IncCRBU | 17 | Buy | $11.00 | +746.15% | Maintains | 4 months ago |
Black Diamond Therapeutics IncBDTX | 15 | Strong Buy | $11.00 | +461.22% | Maintains | 5 months ago |
Biontech SeBNTX | 46 | Buy | $130.00 | +35.33% | Reiterates | 5 months ago |
Molecular Partners AgMOLN | 4 | Buy | $13.00 | +208.79% | Reiterates | 5 months ago |
Allogene Therapeutics IncALLO | 16 | Buy | $11.00 | +550.89% | Maintains | 5 months ago |
Replimune Group IncREPL | 20 | Sell | N/A | N/A | Downgrades | 5 months ago |
Bicara Therapeutics IncBCAX | 6 | Buy | $42.00 | +85.51% | Maintains | 6 months ago |
Perspective Therapeutics IncCATX | 7 | Buy | $13.00 | +351.39% | Maintains | 6 months ago |
Bridgebio Oncology Therapeutics IncBBOT | 2 | Buy | $29.00 | +507.97% | Maintains | 7 months ago |
Tuhura Biosciences IncHURA | 5 | Buy | $10.00 | +376.19% | Reiterates | 8 months ago |
Macrogenics IncMGNX | 19 | Hold | $2.00 | -51.69% | Reiterates | a year ago |
Repare Therapeutics IncRPTX | 19 | Buy | $3.00 | +13.21% | Maintains | a year ago |
Y Mabs Therapeutics IncYMAB | 16 | Hold | $8.60 | N/A | Downgrades | a year ago |
Springworks Therapeutics IncSWTX | 29 | Hold | $47.00 | N/A | Downgrades | a year ago |
Cargo Therapeutics IncCRGX | 4 | Hold | N/A | N/A | Downgrades | 2 years ago |
Atara Biotherapeutics IncATRA | 13 | Hold | N/A | N/A | Reiterates | 2 years ago |
Igm Biosciences IncIGMS | 13 | Hold | $11.00 | N/A | Maintains | 2 years ago |
Kronos Bio IncKRON | 10 | Buy | $2.25 | N/A | Reiterates | 2 years ago |
Omega Therapeutics IncOMGAQ | 9 | Buy | $12.00 | N/A | Reiterates | 2 years ago |
Apollomics IncAPLM | 5 | Buy | $200.00 | N/A | Maintains | 2 years ago |
Viracta Therapeutics IncVIRX | 8 | Buy | $4.00 | N/A | Reiterates | 2 years ago |
Effector Therapeutics IncEFTR | 3 | Buy | $24.00 | N/A | Reiterates | 2 years ago |
Calidi Biotherapeutics IncCLDI | 2 | Buy | $240.00 | N/A | Maintains | 3 years ago |
Kineta IncKANT | 4 | Buy | $8.00 | N/A | Reiterates | 3 years ago |
Alpha Compute CorpALP | 5 | Buy | $120.00 | N/A | Maintains | 3 years ago |
Whitehawk Therapeutics IncWHWK | 9 | Buy | $36.00 | N/A | Maintains | 3 years ago |
Kinnate Biopharma IncKNTE | 7 | Hold | N/A | N/A | Downgrades | 3 years ago |
Gt Biopharma IncGTBP | 6 | Buy | $3,750.00 | N/A | Reiterates | 3 years ago |
Imagenebio IncIMA | 4 | Buy | $264.00 | N/A | Reiterates | 4 years ago |
Tcr2 Therapeutics IncTCRR | 5 | Hold | N/A | N/A | Downgrades | 4 years ago |
Neurogene IncNGNE | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Forma Therapeutics Holdings IncFMTX | 2 | Hold | $20.00 | N/A | Downgrades | 4 years ago |
Turning Point Therapeutics IncTPTX | 6 | Hold | $76.00 | N/A | Downgrades | 4 years ago |
Cytomx Therapeutics IncCTMX | 1 | Buy | $11.00 | N/A | Maintains | 5 years ago |
Nucana PLCNCNA | 7 | Buy | $45,000.00 | N/A | Maintains | 5 years ago |
Autolus Therapeutics PLCAUTL | 1 | Buy | $13.00 | N/A | Maintains | 6 years ago |
Immunomedics IncIMMU | 4 | Hold | $88.00 | N/A | Downgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.